NCT04265599 Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
| NCT ID | NCT04265599 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Herlev Hospital |
| Condition | Hypercalcemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2019-04-30 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2019-04-30 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to characterize paraffin oil induced granulomatous disease. We will investigate pathogenesis and natural history of paraffin disease. Subsequently, through further translational studies, we intend to identify novel treatments to be tested in future randomized clinical trials.
Eligibility Criteria
Inclusion Criteria: * previous intramuscular injection of paraffin or other oil Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04265599 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypercalcemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04265599 currently recruiting?
Yes, NCT04265599 is actively recruiting participants. Contact the research team at ebbe.eldrup@regionh.dk for enrollment information.
Where is the NCT04265599 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT04265599 clinical trial?
NCT04265599 is sponsored by Herlev Hospital. The trial plans to enroll 200 participants.